222 related articles for article (PubMed ID: 25166874)
1. Next-generation companion diagnostics: promises, challenges, and solutions.
Khoury JD; Catenacci DV
Arch Pathol Lab Med; 2015 Jan; 139(1):11-3. PubMed ID: 25166874
[No Abstract] [Full Text] [Related]
2. Regulatory perspectives on next-generation sequencing and complementary diagnostics in Japan.
Shimazawa R; Ikeda M
Expert Rev Mol Diagn; 2020 Jun; 20(6):601-610. PubMed ID: 32064968
[TBL] [Abstract][Full Text] [Related]
3. The evolving potential of companion diagnostics.
Khoury JD
Scand J Clin Lab Invest Suppl; 2016; 245():S22-5. PubMed ID: 27433788
[TBL] [Abstract][Full Text] [Related]
4. Update on molecular companion diagnostics - a future in personalized medicine beyond Sanger sequencing.
Campbell MR
Expert Rev Mol Diagn; 2020 Jun; 20(6):637-644. PubMed ID: 32167388
[TBL] [Abstract][Full Text] [Related]
5. A 2015 update on predictive molecular pathology and its role in targeted cancer therapy: a review focussing on clinical relevance.
Dietel M; Jöhrens K; Laffert MV; Hummel M; Bläker H; Pfitzner BM; Lehmann A; Denkert C; Darb-Esfahani S; Lenze D; Heppner FL; Koch A; Sers C; Klauschen F; Anagnostopoulos I
Cancer Gene Ther; 2015 Sep; 22(9):417-30. PubMed ID: 26358176
[TBL] [Abstract][Full Text] [Related]
6. Advanced Companion Diagnostics Facilities: Opportunity Favors the Prepared Laboratory.
Gruver AM; Schade AE
Arch Pathol Lab Med; 2015 Oct; 139(10):1201. PubMed ID: 26414461
[No Abstract] [Full Text] [Related]
7. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
Paolillo C; Londin E; Fortina P
Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
[TBL] [Abstract][Full Text] [Related]
8. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
Furtado LV; Samowitz WS
Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
[TBL] [Abstract][Full Text] [Related]
9. Next-generation sequencing of cancer genomes: lessons learned.
Corrigan AE; Taylor R; Rallis KS
Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
[No Abstract] [Full Text] [Related]
10. Managing the genomic revolution in cancer diagnostics.
Nguyen D; Gocke CD
Virchows Arch; 2017 Aug; 471(2):175-194. PubMed ID: 28639053
[TBL] [Abstract][Full Text] [Related]
11. Pan-Cancer Biomarkers: Changing the Landscape of Molecular Testing.
Yao J; Arcila ME; Ladanyi M; Hechtman JF
Arch Pathol Lab Med; 2021 Jun; 145(6):692-698. PubMed ID: 33373449
[TBL] [Abstract][Full Text] [Related]
12. Next generation sequencing technologies in cancer diagnostics and therapeutics: A mini review.
Li W; Zhao K; Kirberger M; Liao W; Yan Y
Cell Mol Biol (Noisy-le-grand); 2015 Oct; 61(5):91-102. PubMed ID: 26522064
[TBL] [Abstract][Full Text] [Related]
13. Identification, Prioritization, and Treatment of Mutations Identified by Next-Generation Sequencing.
Mansfield AS; Park BH; Mullane MP
Am Soc Clin Oncol Educ Book; 2018 May; 38():873-880. PubMed ID: 30231389
[TBL] [Abstract][Full Text] [Related]
14. Next-generation sequencing and its applications in molecular diagnostics.
Su Z; Ning B; Fang H; Hong H; Perkins R; Tong W; Shi L
Expert Rev Mol Diagn; 2011 Apr; 11(3):333-43. PubMed ID: 21463242
[TBL] [Abstract][Full Text] [Related]
15. 2019 SEOM guidelines (the end of a decade).
González-Del-Alba A; Rodríguez-Lescure Á
Clin Transl Oncol; 2020 Feb; 22(2):169-170. PubMed ID: 32030655
[No Abstract] [Full Text] [Related]
16. Genetic profiling as a clinical tool in advanced parathyroid carcinoma.
Kutahyalioglu M; Nguyen HT; Kwatampora L; Clarke C; Silva A; Ibrahim E; Waguespack SG; Cabanillas ME; Jimenez C; Hu MI; Sherman SI; Kopetz S; Broaddus R; Dadu R; Wanland K; Williams M; Zafereo M; Perrier N; Busaidy NL
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1977-1986. PubMed ID: 31309300
[TBL] [Abstract][Full Text] [Related]
17. Can protein science solve the unmet needs in pancreatic cancer diagnosis and therapy?
Ansari D; Sambergs F; Johansson L; Andersson R
Expert Rev Proteomics; 2017 Jun; 14(6):469-471. PubMed ID: 28388239
[No Abstract] [Full Text] [Related]
18. Challenges in the clinical implementation of precision medicine companion diagnostics.
Keeling P; Clark J; Finucane S
Expert Rev Mol Diagn; 2020 Jun; 20(6):593-599. PubMed ID: 32336167
[TBL] [Abstract][Full Text] [Related]
19. Integrating next-generation sequencing into clinical cancer diagnostics.
Chan M; Lee CW; Wu M
Expert Rev Mol Diagn; 2013 Sep; 13(7):647-50. PubMed ID: 24063391
[No Abstract] [Full Text] [Related]
20. Precision Medicine Requires Precision Laboratories.
Rajeevan MS; Li T; Unger ER
J Mol Diagn; 2017 Mar; 19(2):226-229. PubMed ID: 28130021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
